The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Hypertriglyceridemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Brunzell, J. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070061 · Cited by 268
Pandor, A., Ara, R. M., Tumur, I., Wilkinson, A. J., Paisley, S., Duenas, A., Durrington, P. N., & Chilcott, J. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02062.x · Cited by 228
Research works printed but not linked: 19
- Berger, 2005, PPARs: therapeuric targets for metabolic disease, Trends Pharmacol. Sci., 26, 244, 10.1016/j.tips.2005.03.003 · DOI · Paper page
- Grundy, 2001, Executive Summary of the Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 · DOI · Paper page
- Fredrickson, 1967, Fat transport in lipoproteins-an integrated approach to mechanisms and disorders, N. Engl. J. Med., 276, 34, 10.1056/NEJM196701052760107 · DOI · Paper page
- Fredrickson, 1967, Fat transport in lipoproteins-an integrated approach to mechanisms and disorders, N. Engl. J. Med., 276, 94, 10.1056/NEJM196701122760206 · DOI · Paper page
- Fredrickson, 1967, Fat transport in lipoproteins-an integrated approach to mechanisms and disorders, N. Engl. J. Med., 276, 148, 10.1056/NEJM196701192760305 · DOI · Paper page
- Fredrickson, 1967, Fat transport in lipoproteins-an integrated approach to mechanisms and disorders, N. Engl. J. Med., 276, 215, 10.1056/NEJM196701262760406 · DOI · Paper page
- Fredrickson, 1967, Fat transport in lipoproteins-an integrated approach to mechanisms and disorders, N. Engl. J. Med., 276, 273, 10.1056/NEJM196702022760507 · DOI · Paper page
- King, 2009, Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and hyperlipidemic hamster, J. Pharmacol. Exp. Ther., 330, 526, 10.1124/jpet.109.154047 · DOI
- Levy, 1966, The nature of pre beta (very low density) lipoproteins, J. Clin. Invest., 45, 63, 10.1172/JCI105324 · DOI · Paper page
- Rosenson, 2003, Lipid lowering with HMG Co-A reductase inhibitors (statins), Up-To-Date, 11
- Rosenson, 2003, Lipid lowering with drugs other than statins and fibrates, Up-To-Date, 11
- Rosenson, 2003, Treatment guidelines for hypercholesterolemia, Up-To-Date, 11
- Avramoglu, 2003, Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion, Front. Biosci., 1, D464
- Chicco, 2003, Muscle lipid metabolism and insulin secretion are altered in insulin-resistant rats fed a high sucrose diet, J. Nutr., 133, 127, 10.1093/jn/133.1.127 · DOI
- Funatsu, 2003, Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model, Metabolism, 52, 609, 10.1053/meta.2003.50097 · DOI
- Tailleux, 2003, Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis, Trends Pharmacol. Sci., 24, 530, 10.1016/j.tips.2003.08.001 · DOI
- Haidari, 2002, J. Biol. Chem., 277, 31646, 10.1074/jbc.M200544200 · DOI · Paper page
- McKenney, J.M., Pharmacotherapy of dyslipidemia, Cardiovasc. Drugs Ther., 15(5) (2001) 413–422. · DOI
- Miller, M., Current perspectives on the management of hypertriglyceridemia, Am. Heart J., 140(2) (2000) 232–240. · DOI
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159228 · Cited by 1,589
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Metadata
- Authors
- Maio, A., & Dowd, F. J.
- Venue
- xPharm: The Comprehensive Pharmacology Reference
- Publisher
- Elsevier
- Published
- 2010
- Pages
- 1-5
- OpenAlex
- W4248443489
- Cited by
- 209
- References
- 3
- FWCI
- 141.96
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertriglyceridemia. https://app.cochat.ai/papers/10.1016/b978-008055232-3.60628-2
- The paper
- Maio, A., & Dowd, F. J. (2010). Hypertriglyceridemia. xPharm: The Comprehensive Pharmacology Reference. https://doi.org/10.1016/b978-008055232-3.60628-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.